Skip to main content
. 2024 Aug 28;25(17):9345. doi: 10.3390/ijms25179345
CR complete response
FFPE formalin-fixed and embedded in paraffin
ICI immune checkpoint inhibitor
IQR interquartile ranges
MSI microsatellite instability
OS Overall survival
PD progressive disease
PFS progression-free survival
PR partial response
ROC receiver operating characteristic
SD stable disease
TMB tumor mutational burden